NOREPINEPHRINE-INDUCED CARDIAC-HYPERTROPHY OF THE CAT HEART

被引:15
|
作者
MARINO, TA [1 ]
CASSIDY, M [1 ]
MARINO, DR [1 ]
CARSON, NL [1 ]
HOUSER, S [1 ]
机构
[1] TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PHYSIOL,PHILADELPHIA,PA 19140
来源
ANATOMICAL RECORD | 1991年 / 229卷 / 04期
关键词
D O I
10.1002/ar.1092290411
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Norepinephrine administration causes progressive hypertrophy of the mammalian heart as measured by myocardial mass. The purpose of this study was to determine the growth response of the myocardial tissue components as well as the myocardial cell itself to norepinephrine. Young, adult cats were given low doses of norepinephrine in dextrose or dextrose alone twice daily for 15 days. On day 16, there were no changes in the animals body weight, right ventricular systolic pressure, right ventricular end-diastolic pressure, heart rate, cardiac index, or blood pressure. However, the right ventricle/body weight, the left ventricle/body weight and the total heart weight/body weight were increased significantly in the norepinephrine treated animals. The increase was on the order of 40%. The cardiac muscle cell was also significantly increased in size and both the right and left ventricular cardiac muscle cells exhibited a dramatic increase in size as measured by cross sectional area. Upon stereological examination it was found that the amount of hypertrophy as seen in the cardiac muscle cells was paralleled by the hypertrophy seen in the other tissue components of the myocardium. The volume density of the muscle cells, the interstitial components, as well as the blood vessel compartment were identical in the control and in the norepinephrine-treated groups. In conclusion, this study demonstrates that the response of the myocardium to norepinephrine is similar to that seen in response to a volume overload rather than that seen in response to pressure overload.
引用
收藏
页码:505 / 510
页数:6
相关论文
共 50 条
  • [21] Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart
    Xu, Yiping
    Li, Xuebiao
    Kong, Minjian
    Jiang, Daming
    Dong, Aiqiang
    Shen, Zhonghua
    Duan, Qunjun
    BIOSCIENCE REPORTS, 2014, 34 : 575 - 582
  • [22] T4-INDUCED CARDIAC-HYPERTROPHY AND THE PERFUSED AND TOTAL MICROVASCULATURE OF THE HEART
    WEISS, HR
    GROVER, GJ
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1987, 65 (09) : 1848 - 1855
  • [23] ALTERED NOREPINEPHRINE METABOLISM AND CARDIAC-HYPERTROPHY IN COPPER-DEFICIENT MICE
    GROSS, AM
    PROHASKA, JR
    FASEB JOURNAL, 1988, 2 (05): : A1422 - A1422
  • [24] CARDIAC-HYPERTROPHY IN RESPONSE TO AN ISOMETRIC TRAINING-PROGRAM IN THE CAT
    MUNTZ, KH
    GONYEA, WJ
    MITCHELL, JH
    CIRCULATION RESEARCH, 1981, 49 (05) : 1092 - 1101
  • [25] EXPERIMENTALLY INDUCED CARDIAC-HYPERTROPHY DUE TO THYROXINE
    MATTFELDT, T
    DRAUTZ, M
    MALL, G
    PATHOLOGE, 1989, 10 (04): : 206 - 211
  • [26] EXPERIMENTAL CARDIAC-HYPERTROPHY INDUCED BY ISOPROTERENOL IN RAT
    SZABO, J
    CSAKY, L
    SZEGI, J
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1975, 46 (03): : 281 - 285
  • [27] DEVELOPMENT OF ISOPROTERENOL-INDUCED CARDIAC-HYPERTROPHY
    TAYLOR, PB
    TANG, Q
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (04) : 384 - 389
  • [28] DIETARY-SODIUM INDUCED CARDIAC-HYPERTROPHY
    HARMSEN, E
    LEENEN, FHH
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (04) : 580 - 586
  • [29] NOREPINEPHRINE INDUCED CARDIAC HYPERTROPHY IN DOGS
    GANS, JH
    CATER, MR
    LIFE SCIENCE PART 1 PHYSIOLOGY & PHARMACOLOGY, 1970, 9 (13): : 731 - &
  • [30] DIURNAL HEART-RATE VARIATION AND CARDIAC-HYPERTROPHY
    GRETLER, DD
    LANG, RM
    JAUHAR, R
    FUMO, MT
    WEINERT, L
    MURPHY, MB
    CLINICAL RESEARCH, 1991, 39 (03): : A748 - A748